In malignancies, CXCR4 has been shown to be overexpressed as compared to non-malignant control tissue and, moreover, to be associated with adverse prognosis in many different types of cancer [5–9], suggesting a role of CXCR4 as a tumor driver. This evidence concerns the gene CXCR4 and neoplasm.